Between the narrative that nothing natural could ever do us any real harm, and scaremongering ideas that – even if it doesn’t act as a gateway to the use of stronger substances – smoking cannabis will turn you into a lazy, paranoid and ultimately useless member of society, the space for nuanced interpretations is … Continued
I started working at Volteface just over a year ago now, during a bizarrely unprecedented time. What I would have liked to be a front-facing position in the advocacy space, suddenly had to be performed from my bedroom, in the gloom and isolation of lockdown hibernation. My experience stood in stark contrast to the … Continued
In this episode Paul, Katya and George break down all the big talking points over the past month in the world of cannabis and drug reform. Topics covered: Germany legalises cannabis, the UK drug strategy, the Taliban troll the world, Malta facing resistance to reform, wider European update and Mice eating cannabis?! Enjoy the … Continued
This week Volteface examines the emerging and seemingly booming CBD industry. In this piece we had the opportunity to discuss the topic with Paul Moore, patient advocate and Chief Executive Officer at Green Machine CBD. Moore discussed the vast potential applications and benefits that the CBD business offers to both the UK and Europe. … Continued
Suppose someone told you that two innovative industries were poised to revolutionise healthcare and create tens of thousands of jobs in the process. They would contribute billions to our COVID-stricken economy whilst attracting global talent and investment to our shores. They would also showcase the benefits of divergence from the European Union. Anyone would … Continued
The New Leaf Opportunities campaign has highlighted the economic benefits, innovations and investment opportunities that medical cannabis and CBD can bring to the UK. It has also focused on how celebrating this will lead to a more vibrant cannabis sector. This report has honed in on the opportunities that medical cannabis and CBD bring … Continued
In a recent Sunday Times Magazine article Megan Agnew sheds light on the issue of cannabis and psychosis. The article features some compelling personal stories from people who have struggled with cannabis use, and subsequently developed psychosis. As stated in the article, cannabis is the most commonly used drug in the UK. While cannabis use … Continued
The House of Commons debate last Monday was a fantastic display of support and solidarity for families, campaigners and advocates alike, all hoping to expand access to medical cannabis that remains almost entirely inaccessible on the NHS. Speakers from across the House offered emotional and impassioned pleas for intervention by Under Secretary for Health Jo … Continued
We know a lot about cannabis. Anecdotally, through academic studies, and even Seth Rogen & Snoop Dogg’s twitter accounts. However, women’s relationship to and use patterns with cannabis are rarely discussed. Women’s pain is internal and inherent. We are directed as a first port of call toward medicines that carry risks of blood clots higher … Continued
When discussing cannabis reform, it’s often in relation to the immediate spheres of society, where prohibition has taken priority over harm reduction, and consumers are at immediate risk of harms perpetuated by existing policy. Undoubtedly this is an important focal point, especially in the UK where we still have some way to go with respect … Continued